| 16th September 2015
We are pleased to announce that Blue Latitude have been reappointed to provide Janssen with strategic support and creative marketing services for their brand teams in the EMEA region. Following this renewed three year contract, we will continue our successful partnership with Janssen, offering our full breadth of services across a wide range of therapy areas. Talking about the partnership, leadership from both companies had the following to say;
The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology (e.g., multiple myeloma and prostate cancer), immunology (e.g., psoriasis), neuroscience (e.g., schizophrenia, dementia and pain), infectious disease (e.g., HIV/AIDS, hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g., diabetes). Driven by a commitment to patients, Janssen develops sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency. For their latest news, follow Janssen on Twitter: @JanssenEMEA.
| 13th April 2017
Co-founder and Managing Director Martin Brass will join a panel of industry speakers at the PM Society event ‘Maximising the agency and procurement relationship in pharma’ on 25th April at the Royal Society of Medicine in London.
| 13th February 2017
We are proud to support Rays of Sunshine, the UK charity working with children and young people with serious or life-limiting illness, by developing a creative concept for the #kisses4wishes campaign. The eye-catching campaign launched today in Time Out London as part of its Valentine’s Day edition, in a specially designed gatefold wraparound cover.
| 16th January 2017
Not only was 2016 a milestone year for Blue Latitude Health, we also hired 21 new employees. How are they getting on at BLH, you ask? There’s no one better to explain how they’ve fared in their new roles than our new joiners themselves.